首页> 外文期刊>Pakistan Veterinary Journal >Sequence and Structural Analysis of Synthetic VP2 Antigenic Protein as a Subunit Vaccine Candidate against Very Virulent Strains of Infectious Bursal Disease Virus
【24h】

Sequence and Structural Analysis of Synthetic VP2 Antigenic Protein as a Subunit Vaccine Candidate against Very Virulent Strains of Infectious Bursal Disease Virus

机译:合成VP2抗原蛋白作为感染性愈伤症病毒非常毒性菌株的亚基疫苗候选的序列与结构分析

获取原文
获取原文并翻译 | 示例
           

摘要

Infectious bursal disease virus (IBDV) causes immunosuppression in poultry (3 to 6 weeks age), resulting in severe production and economic losses. Current vaccination strategies exploit live attenuated or killed vaccines based on classical virulent IBDV strains, which are proven to be ineffective against variant and/or very virulent (vv) strains - currently circulating in the field throughout the world. Keeping in view the urgent need of clean and cost-effective vaccines of high quality, we have engineered VP2 gene as host protective major antigen. The gene was synthesized to express in chloroplast genome, plastome. Sequence and structural characterization of synthetic gene and corresponding protein were carried out using a variety of molecular biology and bioinformatics tools. In silico physico-chemical analysis demonstrated that the synthetic VP2 was an acidic protein of 54KDa. Moreover, it was found to be highly thermo-stable with a computed instability index of 30.38 and hydrophobic in nature with GRAVY index of 0.115. The sequence analyses including phylogeny and multiple sequence alignment with representative classical, attenuated and vv IBDV strains from different regions of the world exhibited antigenic similarity with currently circulating vvIBDV strains and predicted its worldwide effectiveness as a subunit vaccine. The 3D structure prediction using I-TASSER server and surface representation of epitopic loops on VP2 trimer using UCSF Chimera software indicated the potential of synthetic VP2 as an antigenic protein. The generated information has paved the way for the functional characterization of synthetic protein as a subunit vaccine employing transgenic approaches in future. (C) 2018 PVJ. All rights reserved
机译:感染性Bursal疾病病毒(IBDV)导致家禽(3至6周龄)的免疫抑制,导致严重的生产和经济损失。目前的疫苗接种策略基于古典毒力IBDV菌株利用现场减毒或杀死的疫苗,这被证明是对各种世界的变异和/或非常毒力(VV)菌株无效 - 目前在全世界的领域循环。为了看来,迫切需要清洁和经济高质量的疫苗,我们已经设计了VP2基因作为宿主保护主要抗原。合成基因以表达叶绿体基因组,塑性。使用各种分子生物学和生物信息学工具进行合成基因和相应蛋白质的序列和结构表征。在硅的物理学分析中,证明合成VP2是54kda的酸性蛋白质。此外,发现具有30.38的计算不稳定指数的高度热稳定,本质上具有0.115的肉汁指数的疏水性。与来自世界的不同区域的序列分析包括系统发育和多序列比对,以及来自世界不同地区的衰减和VV IBDV菌株与目前循环的VVIBDV菌株表现出抗原相似性,并预测其作为亚基疫苗的全球效果。使用UCSF Chimera软件在VP2三聚体上使用I-Tasser Server和O-Tasser Server的表面表示的3D结构预测表明了合成VP2作为抗原蛋白的电位。生成的信息已经为合成蛋白质的功能表征为未来采用转基因方法的亚基疫苗铺平了合成蛋白的功能表征的方式。 (c)2018 PVJ。版权所有

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号